InMed Pharmaceuticals Added to CSE25 Index

- September 21st, 2017

InMed Pharmaceuticals announced that it has been included in the CSE25 Index.

InMed Pharmaceuticals (CSE:IN; OTCQB:IMLFF) announced that it has been included in the CSE25 Index.
As quoted in the press release:

InMed qualified for the index as one of the twenty-five largest companies in the CSE Composite Index.

About the CSE25 Index
On September 18, 2017, the Canadian Securities Exchange (“CSE”) announced the introduction of a new index comprised of the securities of the largest companies trading on the exchange.

Click here to read the full press release.


Get the latest Cannabis Investing stock information

Get the latest information about companies associated with Cannabis Investing Delivered directly to your inbox.

Cannabis Investing

Select None
Select All

Leave a Reply